Svmk Inc (SVMK)

21.55  +0.26 (+1.22%)

After market: 21.55 0 (0%)

Fundamental Rating

2

Overall SVMK gets a fundamental rating of 2 out of 10. We evaluated SVMK against 277 industry peers in the Software industry. Both the profitability and financial health of SVMK have multiple concerns. While showing a medium growth rate, SVMK is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SVMK has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -10.83%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -22.11%
PM (TTM) -24.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

SVMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.72 indicates that SVMK is not a great score, but indicates only limited risk for bankruptcy at the moment.
SVMK has a Debt/Equity ratio of 0.61. This is a neutral value indicating SVMK is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.17 indicates that SVMK should not have too much problems paying its short term obligations.
SVMK has a Quick Ratio of 1.17. This is a normal value and indicates that SVMK is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
The Revenue has grown by 19.14% in the past year. This is quite good.
Measured over the past years, SVMK shows a quite strong growth in Revenue. The Revenue has been growing by 16.02% on average per year.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q33.33%
Revenue 1Y (TTM)19.14%
Revenue growth 3Y19.74%
Revenue growth 5Y16.02%
Revenue growth Q2Q15.9%

3.2 Future

SVMK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 246.73% yearly.
SVMK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.68% yearly.
EPS Next Y400.9%
EPS Next 2Y325.75%
EPS Next 3Y234.95%
EPS Next 5Y246.73%
Revenue Next Year18.43%
Revenue Next 2Y19.12%
Revenue Next 3Y18.94%
Revenue Next 5Y18.68%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVMK. In the last year negative earnings were reported.
SVMK is valuated quite expensively with a Price/Forward Earnings ratio of 133.63.
The average S&P500 Price/Forward Earnings ratio is at 20.34. SVMK is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 133.63

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -77.78

4.3 Compensation for Growth

SVMK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVMK's earnings are expected to grow with 234.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y325.75%
EPS Next 3Y234.95%

More info and screens

0

5. Dividend

5.1 Amount

SVMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Svmk Inc

NASDAQ:SVMK (6/14/2021, 7:00:01 PM)

After market: 21.55 0 (0%)

21.55

+0.26 (+1.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.14B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 133.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -22.11%
PM (TTM) -24.89%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y400.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.14%
Revenue growth 3Y19.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y